BioPharmSignal logoBioPharmSignal

Biotech News

Hyperfine Reports Record Preliminary Third Quarter Revenue of Approximately $6.0 Million & Reaffirms Full Year 2026 Revenue Outlook of Approximately $20 to $22 Million

Hyperfine (HYPR)HyperfineEarnings

Preliminary Revenue Represents 53% Sequential Quarterly Growth; Company Reaffirms 2026 Financial Guidance and Expects Quarter-End Cash and Cash Equivalents of Approximately $37.9 Million GUILFORD, Conn. --(BUSINESS WIRE)--Oct. 8, 2026-- Hyperfine, Inc.

Related news

HYPRHyperfine2026-10-08 11:30 EST

Hyperfine, Inc. to Announce Third Quarter 2026 Financial Results on November 9, 2026

HYPRHyperfine2026-08-06 20:05 EST

Hyperfine, Inc. Reports Second Quarter 2026 Financial Results

XAIRBeyond Air2026-10-08 12:00 EST

Beyond Air® Preannounces Preliminary Revenue for the Quarter Ended September 30, 2026

IARTIntegra LifeSciences2026-10-02 12:05 EST

Integra LifeSciences Announces Preliminary Third Quarter Results and Updates Full-Year 2026 Guidance

SHCSotera Health2026-08-06 11:00 EST

Sotera Health Delivers Strong Second-Quarter and First-Half 2026 Results and Raises FY 2026 Outlook

RXSTRxSight2026-08-05 20:05 EST

RxSight, Inc. Reports Second Quarter 2026 Results and Provides Update on 2026 Outlook

MMSIMerit Medical2026-07-30 20:05 EST

Merit Medical Reports Second Quarter 2026 Results And Updates Full-Year 2026 Guidance

ACHCAcadia Healthcare2026-07-28 20:05 EST

Acadia Healthcare Announces Second Quarter 2026 Results and Updates Full Year 2026 Financial and Cash Flow Guidance

ANGOAngioDynamics2026-10-08 10:02 EST

AngioDynamics Reports Fiscal Year 2027 First Quarter Financial Results; Continued Execution Drives Med Tech Growth and Profitability

IARTIntegra LifeSciences2026-10-06 12:30 EST

Integra LifeSciences to Host Third Quarter 2026 Financial Results Conference Call on October 21, 2026

View all latest news

Hyperfine

Portable Brain MRI Company Hyperfine develops the Swoop portable magnetic resonance brain-imaging system for use at the patient’s bedside and in settings without conventional MRI infrastructure. Low-Field Imaging Platform Swoop uses low-field magnetic resonance and can be moved through hospitals, reducing the logistical burden of...

Recent company news

HYPRHyperfine2026-10-08 11:30 EST

Hyperfine, Inc. to Announce Third Quarter 2026 Financial Results on November 9, 2026

HYPRHyperfine2026-10-08 11:30 EST

Hyperfine Reports Record Preliminary Third Quarter Revenue of Approximately $6.0 Million & Reaffirms Full Year 2026 Revenue Outlook of Approximately $20 to $22 Million

HYPRHyperfine2026-09-28 12:15 EST

Hyperfine Expands Global Access to Portable Brain MRI Technology Across Key Gulf Cooperation Council Healthcare Markets

HYPRHyperfine2026-09-15 12:15 EST

Hyperfine Announces Completion of Enrollment in the Contrast PMR Study to Support the Submission to Expand Indications for Use of the Swoop® System with Contrast Agents

HYPRHyperfine2026-08-31 12:15 EST

Hyperfine, Inc. to Participate in Lake Street Capital Markets 10th Annual Best Ideas Growth Conference

Stock data

Close
0.87 USD
Market cap
148.91M USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States